What is DIRECTSYNC SURGICAL?
DirectSync Surgical is at the forefront of revolutionizing the research, design, and development processes for orthopedic and spinal implantable devices. By focusing on innovative methodologies, the company aims to streamline the creation of advanced medical technologies. This strategic focus positions DirectSync Surgical as a key player in enhancing the capabilities of the medical device industry, driving progress in patient care through superior product development.
How much funding has DIRECTSYNC SURGICAL raised?
DIRECTSYNC SURGICAL has raised a total of $12K across 1 funding round:
Debt
$12K
Debt (2021): $12K with participation from PPP
Key Investors in DIRECTSYNC SURGICAL
PPP
Public-Private Partnership
What's next for DIRECTSYNC SURGICAL?
With the recent influx of moderate growth capital, DirectSync Surgical is poised for an accelerated expansion phase. The Series A/B growth stage funding indicates a strategic intent to scale operations, enhance research and development initiatives, and potentially broaden its market reach. Future developments are expected to focus on solidifying its technological advantages and expanding its portfolio of orthopedic and spinal solutions, further cementing its role as an innovator in the medical technology field.
See full DIRECTSYNC SURGICAL company page
